Corpus Intelligence IC Memo — CENTRO DE SALUD CONDUCTUAL MENONITA 2026-04-26 15:53 UTC
IC Memo — CENTRO DE SALUD CONDUCTUAL MENONITA
Investment Committee Memorandum | PR | 61 beds | Grade D | EBITDA uplift $657K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CENTRO DE SALUD CONDUCTUAL MENONITA

CCN 404009 | AIBONITO PR, PR | 61 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CENTRO DE SALUD CONDUCTUAL MENONITA is a 61-bed community hospital in AIBONITO PR, PR with $8.8M in net patient revenue and a -64.9% operating margin. The hospital serves a payer mix of 4.1% Medicare, 0.0% Medicaid, and 95.9% commercial.

Thesis: Turnaround. Our ML models identify $657K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -64.9% to -57.4% (+744bps).

Net Revenue HCRIS$8.8M
Current EBITDA COMPUTED$-5.7M
Operating Margin COMPUTED-64.9%
Occupancy HCRIS79.3%
Revenue / Bed COMPUTED$145K
Net-to-Gross HCRIS42.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

61
PR Hospitals
-8.8%
State Median Margin
21
Comparable Hospitals

PR has 61 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -64.9% places it below the state median. Among 21 size-comparable peers (30-122 beds), the median margin is -8.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-122), prioritizing same-state peers. 21 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CENTRO DE SALUD CONDUCTUAL MEN (Target)PR61$8.8M-64.9%
ADMIN DE SERVICIOS MEDICOS DE PR65$179.7M-50.0%
HOSPITAL MENONITA HUMACAOPR73$53.1M31.3%
METRO MAYAGUEZPR122$50.5M-2.9%
HOSPITAL DR. SUSONIPR119$46.5M-4.9%
HOSPITAL DR. PILAPR115$43.3M-5.7%
HOSPITAL WILMA N VAZQUEZPR100$37.6M5.6%
DOCTORS CENTER HOSPITAL CAROLIPR109$35.5M-4.3%
HOSPITAL METRO HATO REY INC.PR84$34.2M-18.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $657K (744bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$185K+210bp18mo
Denial Rate Reduction12.0%6.5%$178K+202bp12mo
Cost to Collect4.5%2.5%$177K+200bp12mo
A/R Days Reduction5200.0%3800.0%$107K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+11bp6mo

5. EBITDA Bridge

Net Collection Rate
$185K
Denial Rate Reduction
$178K
Cost to Collect
$177K
A/R Days Reduction
$107K
Clean Claim Rate
$10K
Total EBITDA Uplift$657K
Current EBITDA$-5.7M
+ RCM Uplift+$657K
Pro Forma EBITDA$-5.1M
Current Margin-64.9%
Pro Forma Margin-57.4%
WC Released (1x)$339K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.8M$-31.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.8M$-37.2M0.00x-100.0%
Bull Case9.0x11.0x$-7.9M$-37.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.9M$-43.7M0.00x-100.0%
Bear Case11.0x10.0x$-9.7M$-31.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.7M$-38.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 21 hospitals with 30-122 beds
  • Same-state prioritization (n=22)
  • Comp margins: P25=-23.2% / P50=-8.2% / P75=-1.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.